<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=4234353&amp;fmt=gif">

FutureLabs: Transforming laboratory design to expedite research and development

Revolutionizing labs with integrated Quantum Computing  

In an era dominated by AI and digital progress, life sciences design must evolve to maintain the status quo. At the 2023 ISPE Annual Meeting, Bobby Savarese, Senior Principal, Unispace Life Sciences shared insights about how laboratory and regulatory environments will need to harness the power of technology to rethink their design strategies and leverage the transformative impact of Quantum Computing.

Innovation in the biotech and pharma industry is critical to stay competitive and keep up with the dynamic landscape. How can companies get ahead and stay ahead? We’ve developed a technology-enabled solution designed to expedite the R&D project cycle. This solution is engineered to facilitate quicker reliance for drug discovery programs, a crucial aspect in today's competitive and fast-paced environment.

The art of integration

Utilizing innovative technology in R&D is not a novel concept. However, our laboratory design approach is distinctive—bringing regulators, R&D experts, production teams, and market experts together to increase collaboration and expedite the R&D project cycle. By blending technologies such as Lab Information Management Systems (LIMS), digital lab twin technology, AI applications, cybersecurity, biosafety measures, and Quantum Computing, a virtual collaborative space is created—fostering collaboration to significantly accelerate the process of securing reliance and recognition for new drug discovery.

Quantum Computers in labs: Closer than you think 

At one point, the possibility of Quantum Computers in labs was beyond reach. Now, laboratories are beginning to incorporate this advanced technology, offering an edge in data analysis for drug discovery. This integration has the potential to exponentially expedite decision-making for both scientists and regulators, making it a game-changing asset.

"In our FutureLabs solution, Quantum Computing isn’t just a technology; it’s the catalyst for a ‘friendly collision course’ where regulators, R&D experts, production teams, and commercial minds converge in a space for innovation. This collaboration is a game-changer, accelerating the path from idea to market and transforming the future of laboratory design and R&D."
– Bobby Savarese, Senior Principal, Unispace Life Sciences

Envisioning the future 

FutureLabs is a pioneering concept defining the next generation of laboratory design and life science engineering in the realm of R&D. By integrating innovative technologies and fostering collaboration, it promises to revolutionize the R&D project cycle, offering quicker reliance and recognition for drug discovery programs. 

The inclusion of Quantum Computing in life science construction is not a distant dream but a reality on the horizon. It represents a continuous journey of introducing cutting-edge technologies while optimizing resource allocation within adaptable laboratory spaces. This enables capital and life cycle operating costs to be reduced while ensuring safety, sustainability, and productivity.  

Get in touch if you would like to learn more about Unispace Life Sciences FutureLabs and our approach. 

About Bobby Savarese, Senior Principal, Life Sciences

Bobby Saverse_424px


Bobby draws upon his experience in delivering end-to-end Design & Build solutions for our Life Science R&D partners. His previous roles included overseeing global key accounts within the Life Sciences sector, where he applied his expertise to deliver client-centric solutions. Bobby has also made contributions as the Vice President of a global Biotech Life Sciences company, driving innovation through the introduction of advanced technologies and championing the adoption of integrative modular solutions within the Life Sciences industry.

Connect with Bobby on LinkedIn